Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
Clinical trial NCT05706454 · UNKNOWN
Trial details
- NCT number
- NCT05706454
- Sponsor
- KARE Biosciences
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2024-07-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.